Explore
Palvella Therapeutics, IncPVLA
$148.00+2.29%24H
PVLA / USDNASDAQ
Use arrow keys to change the interval
Equity Info
P/E Ratio—
Market Cap$2.22B
EPS-5.52
52 Week Range$72.22 - $179.95
Volume$47.69M
Liquidity Score—
About Palvella Therapeutics, Inc

Palvella Therapeutics, Inc. is an innovative biotechnology firm dedicated to developing transformative therapies for rare genetic disorders resulting from specific gene mutations. Its lead investigational product specifically targets pachyonychia congenita, directly addressing significant unmet medical needs within this niche patient population. With a strong focus on gene therapy and a strategic pipeline expansion, Palvella is poised to set new standards in the treatment of rare diseases, making it a compelling investment prospect for institutional investors looking to capitalize on growth in the biotech landscape.

HeadquartersWAYNE, PA

Buy

—
—

Assets

Asset
Palvella Therapeutics
rPVLA
Reality Finance
Trending
ROKU
Roku Inc
$160.540.07%
No chart data availableHistorical price data isn't available for this asset yet.
Details
KVUE
Kenvue Inc.
$19.271.53%
No chart data availableHistorical price data isn't available for this asset yet.
Details
SPG
Simon Property Group Inc
$220.505.30%
Details

Help